Explorative Study of AZD1305 in Atrial Fibrillation Patients

NCT00643448 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: AZD1305
DRUG: AZD1305
DRUG: Placebo

Sponsor

AstraZeneca